A REVIEW ARTICLE ON MUSCULAR DYSTROPHY AND ITS MANAGEMENT THROUGH AYURVEDA

M. Meena
{"title":"A REVIEW ARTICLE ON MUSCULAR DYSTROPHY AND ITS MANAGEMENT THROUGH AYURVEDA","authors":"M. Meena","doi":"10.20959/WJPR201711-9629","DOIUrl":null,"url":null,"abstract":"Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy caused by the absence of dystrophin gene. It is an X-linked inherited disorder without involvement of nervous system, progressive degeneration of group of muscle characterized by mildly delayed motor milestones, slow and progressive muscle weakness start presenting soon after the age of 3 years. Severe weakness and wasting occurs in proximal muscles of lower limbs. The Incidence of Duchenne muscular dystrophy is 1 in 3500 live male. Most common cause of death in DMD is cardiomyopathy and respiratory insufficiency. In modern medicine no successful therapy for treating DMD cases except corticosteroid‟s i.e. Deflazacort. Muscular dystrophy cannot be directly co-related with any single disease in Ayurvedic texts. It can be correlated to Vata vyadhi in Ayurvedic text. In Ayurveda muscular dystrophy may be clearly understood by the concept of Adhi bala pravritta vyadhi here the pathogenesis occurs due to the Beeja bhagavayava dusti which leads to Mamsa vata dushti. The present review article reveals highlights on various Ayurvedic medicines along with Panchkarma (Snehan, SSPS, and Basti karma) therapy for treatment and prevention of muscular dystrophy.","PeriodicalId":23796,"journal":{"name":"World journal of pharmaceutical research","volume":"18 1","pages":"378-388"},"PeriodicalIF":0.0000,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of pharmaceutical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20959/WJPR201711-9629","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy caused by the absence of dystrophin gene. It is an X-linked inherited disorder without involvement of nervous system, progressive degeneration of group of muscle characterized by mildly delayed motor milestones, slow and progressive muscle weakness start presenting soon after the age of 3 years. Severe weakness and wasting occurs in proximal muscles of lower limbs. The Incidence of Duchenne muscular dystrophy is 1 in 3500 live male. Most common cause of death in DMD is cardiomyopathy and respiratory insufficiency. In modern medicine no successful therapy for treating DMD cases except corticosteroid‟s i.e. Deflazacort. Muscular dystrophy cannot be directly co-related with any single disease in Ayurvedic texts. It can be correlated to Vata vyadhi in Ayurvedic text. In Ayurveda muscular dystrophy may be clearly understood by the concept of Adhi bala pravritta vyadhi here the pathogenesis occurs due to the Beeja bhagavayava dusti which leads to Mamsa vata dushti. The present review article reveals highlights on various Ayurvedic medicines along with Panchkarma (Snehan, SSPS, and Basti karma) therapy for treatment and prevention of muscular dystrophy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿育吠陀治疗肌肉萎缩症的综述
杜氏肌营养不良症(DMD)是由肌营养不良蛋白基因缺失引起的最常见的肌营养不良症。这是一种不累及神经系统的x连锁遗传性疾病,以轻度延迟运动里程碑为特征的肌肉群进行性变性,3岁后不久开始出现缓慢和进行性肌肉无力。下肢近端肌肉出现严重无力和萎缩。杜氏肌营养不良症的发病率为1 / 3500。DMD最常见的死亡原因是心肌病和呼吸功能不全。在现代医学中,除使用皮质类固醇外,尚无成功的治疗DMD的方法。在阿育吠陀文献中,肌肉萎缩症不能与任何一种疾病直接相关。它可以与阿育吠陀文本中的Vata vyadhi相关联。在阿育吠陀中,肌肉萎缩症可以通过Adhi bala pravritta vyadhi的概念来清楚地理解,这里的发病机制是由于Beeja bhagavayava dusti导致Mamsa vata dushti。目前的综述文章揭示了各种阿育吠陀药物以及Panchkarma (Snehan, SSPS和Basti karma)治疗和预防肌肉萎缩症的重点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Effect of caffeine on the acceptability of novel flavoured drinks. FORMULATION AND DEVELOPMENT OF FLURBIPROFEN CONTAINING FILM FORMING GEL EVALUATION OF CLINICAL EFFICACY OF GANDHAKAKALPA IN VICHARCHIKA A COMPREHENSIVE REVIEW ON GASTRORETENTIVE FLOATING TABLET OF CAPTOPRIL USING NATURAL AND SYNTHETIC POLYMER WITH COMPARISION OF POLYMER EFFICACY IN- SITU NASAL GEL: MODERNISTIC ADVANCEMENT IN DRUG DELIVERY
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1